跳至主要内容
临床试验/NCT07130227
NCT07130227已完成不适用

The Effect of MBRS-Based Psychoeducation on Anger Management and Functional Recovery in Patients With Schizophrenia

Ataturk University1 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2021年3月30日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
75
试验地点
1
主要终点
Personal Information Form

研究概览

简要总结

This study aimed to determine the effects of mindfulness-based stress reduction training on anger management and functional recovery in patients with schizophrenia. The study will be conducted at a CMHC in Ağrı province between May and August 2021. At the CMHC, community-based mental health services are provided to patients with severe mental disorders (schizophrenia, bipolar disorder) who are in remission as assessed by a psychiatrist. The study is planned to be conducted with patients who meet the study criteria, without using a sample selection method. Patients over the age of 18 registered with CMHC and followed with a diagnosis of schizophrenia were contacted by phone and invited to CMHC. The study was conducted with patients who met the inclusion criteria and agreed to participate (psychoeducational group, mindfulness group, control group). Data will be collected using the Descriptive Characteristics Form, the State and Trait Anger Inventory, and the SILO. The mindfulness group received 16 sessions of MBRS training, and the psychoeducational group received an 8-session psychoeducational program. The control group received no intervention. The study sample size was calculated using the GPower computer program. Power analysis at α=0.05 yielded an effect size of 150, 153 (d=0.8), and the study had 90% power. Therefore, it was calculated that a minimum of 68 patients should be included in the sample.

详细描述

Study data were collected by the researcher through face-to-face interviews. The study included individuals diagnosed with schizophrenia who met the inclusion criteria (registration in a CMHC, having a diagnosis of schizophrenia, willingness to participate in the study, and openness to communication and collaboration). Pre-test measurement instruments were administered to the participants. The mindfulness group then received 16 sessions of MBRS training, and the psychoeducation group received an 8-session psychoeducation program. The control group received no intervention. Post-test data were collected following the training sessions.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Being registered with a CMHC
  • •Being diagnosed with schizophrenia
  • •Being between the ages of 18 and 60
  • •Being willing to participate in the study
  • •Being open to communication and cooperation
  • •Being in remission

排除标准

  • •Not being open to communication and cooperation

研究组 & 干预措施

Group 2: Session 7: Relaxation

Active Comparator

Performing the relaxation CD with patients

干预措施: Session 7: Group 2, Relaxation (Other)

Group 2: Session 6: What is relaxation?

Active Comparator

What is progressive relaxation. Relaxation CD introduction

干预措施: Session 6: Group 2, What is relaxation? (Other)

Group 2: Session 8: Evaluation

Active Comparator

*Reinforcement of what has been learned. *Evaluation of the program. *Receiving feedback

干预措施: Session 8: Group 2, Evaluation (Other)

Group 2: Session 1: Preparatory Session

Active Comparator

*Meeting the patients *Introducing the content of psychoeducation *Emphasizing the importance of regular and timely attendance at training *Determining training dates *Sharing individuals' experiences and expectations

干预措施: Session 1: Group 2, Preparation Session (Other)

Session 1: Preparatory Session

Experimental

*Meeting the patients *Introducing the content of mindfulness-based stress reduction training *Emphasizing the importance of regular and timely attendance at training *Determining training dates *Sharing individuals' experiences and expectations

干预措施: Session 1: Preparatory Session (Other)

Session 2: Mindfulness

Experimental

*What is mindfulness? *Being aware of daily activities. *Raisin meditation.

干预措施: Session 2: Mindfulness (Other)

Session 3: Our Perspectives on Ourselves and the World

Experimental

*Breathing meditation. *Habit Breaker: Watching the Sky.

干预措施: Session 3: Our Perspectives on Ourselves and the World (Other)

Session 4: Body Scan *Body scan meditation.

Experimental

*Ten-finger gratitude practice. *Habit Breaker: Spending some time in nature.

干预措施: Session 4: Body Scan *Body scan meditation. (Other)

Session 5: Recognizing Schizophrenia

Experimental

*What is schizophrenia? *What are its symptoms? *What does treatment involve?

干预措施: Session 5: Recognizing Schizophrenia (Other)

Session 6: Mindful Movement

Experimental

*Mindfulness movement meditation practice *

干预措施: Session 6: Mindful Movement (Other)

Session 7: Mindful Breathing

Experimental

*Breathing meditation

干预措施: Session 7: Mindful Breathing (Other)

Session 8: Treatment Evaluation

Experimental

*The importance of medication *Things to consider when using medication *Side effects of medication *What is a flare-up in schizophrenia? *What are the precursor symptoms?

干预措施: Session 8: Treatment Evaluation (Other)

Session 9: Mindful Thinking

Experimental

*Sounds and thoughts meditation *Cinema activity.

干预措施: Session 9: Mindful Thinking (Other)

Session 10: Coping with Anger

Experimental

*What is anger? *What are its symptoms? *What are the coping methods?

干预措施: Session 10: Coping with Anger (Other)

Session 11: Coping with Difficult Emotions

Experimental

*Facing Difficulties meditation

干预措施: Session 11: Coping with Difficult Emotions (Other)

Session 12: Mindful Communication

Experimental

*Communication & mindful communication *The importance of communication skills *Fundamentals of communication, self-language practice *Ways to prevent communication accidents

干预措施: Session 12: Mindful Communication (Other)

Session 13: Different Connections

Experimental

*Breathing meditation. *Habit Breaker: Thought and Emotional Play.

干预措施: Session 13: Different Connections (Other)

Session 14: The Joy of the Small Things

Experimental

*Treasure Treasure Meditation *Habit Breaker: Letter to Self.

干预措施: Session 14: The Joy of Small Things (Other)

Session 15: Dwelling on the Past or Living in the Present?

Experimental

*Friendship-Building Meditation *Habit Breaker: Random Acts of Kindness.

干预措施: Session 15: Dwelling on the Past or Living in the Present? (Other)

Session 16: Evaluation *Reinforcing What Has Been Learned.

Experimental

*Evaluating the Program. *Obtaining Feedback.

干预措施: Session 16: Evaluation (Other)

Group 2: 2: Recognizing the Illness

Active Comparator

*What is schizophrenia? *What are its symptoms? *What does treatment involve?

干预措施: Session 2: Group 2, Recognizing the Illness (Other)

Group 2: Session 3: Evaluating Treatment

Active Comparator

*Considerations regarding medication use *Side effects of medication use *Exacerbations in schizophrenia *Premonitory symptoms.

干预措施: Session 3: Group 2, Treatment Evaluation (Other)

Group 2: Session 4: *What is anger?

Active Comparator

*What are the symptoms of anger? *What are the methods for coping with anger?

干预措施: Session 4: Group 2, What is anger? (Other)

Group 2: Session 5: Communication *What is communication?

Active Comparator

*The importance of communication. *Fundamentals of communication, self-language practice *Ways to prevent communication difficulties.

干预措施: Session 5: Group 2, Communication (Other)

结局指标

主要结局

Personal Information Form

时间窗: up to 1 day

This form consists of a total of eight questions (age, gender, marital status, education level, duration of illness, income, family history of mental illness, and employment status) developed by the researcher based on literature and includes the sociodemographic characteristics of the patients

次要结局

  • The State-Trait Anger Scale (STAS)(up to 1 day)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mine CENGİZ

Lecturer Physician

Ataturk University

研究点 (1)

Loading locations...

相似试验

MBRS-Based Psychoeducation in Patients With... | 临床试验